These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9772380)

  • 21. Historical review: ATP as a neurotransmitter.
    Burnstock G
    Trends Pharmacol Sci; 2006 Mar; 27(3):166-76. PubMed ID: 16487603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Roles of adenosine receptors in Alzheimer's disease].
    Yan R; Hu ZY; Zhou WX; Wang Q; Zhang YX
    Yao Xue Xue Bao; 2014 Jun; 49(6):751-6. PubMed ID: 25212017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of adenosine in mediating cellular and molecular responses to ethanol.
    Diamond I; Gordon AS
    EXS; 1994; 71():175-83. PubMed ID: 8032148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proposal of a guanine-based purinergic system in the mammalian central nervous system.
    Schmidt AP; Lara DR; Souza DO
    Pharmacol Ther; 2007 Dec; 116(3):401-16. PubMed ID: 17884172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenosine receptors and neurological disease: neuroprotection and neurodegeneration.
    Stone TW; Ceruti S; Abbracchio MP
    Handb Exp Pharmacol; 2009; (193):535-87. PubMed ID: 19639293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenosine and dopamine receptor interactions in striatum and caffeine-induced behavioral activation.
    Xie X; Ramkumar V; Toth LA
    Comp Med; 2007 Dec; 57(6):538-45. PubMed ID: 18246865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenosine and suppression of seizures.
    Dunwiddie TV
    Adv Neurol; 1999; 79():1001-10. PubMed ID: 10514882
    [No Abstract]   [Full Text] [Related]  

  • 28. Adenosine and renal tubular function.
    Di Sole F
    Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):399-407. PubMed ID: 18660677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenosine and its receptors: multiple modulatory functions and potential therapeutic targets for neurologic disease.
    Benarroch EE
    Neurology; 2008 Jan; 70(3):231-6. PubMed ID: 18195269
    [No Abstract]   [Full Text] [Related]  

  • 30. Adenosine Receptors in Modulation of Central Nervous System Disorders.
    Choudhury H; Chellappan DK; Sengupta P; Pandey M; Gorain B
    Curr Pharm Des; 2019; 25(26):2808-2827. PubMed ID: 31309883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review).
    Hoskin DW; Mader JS; Furlong SJ; Conrad DM; Blay J
    Int J Oncol; 2008 Mar; 32(3):527-35. PubMed ID: 18292929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-substituted adenosines as novel neuroprotective A(1) agonists with diminished hypotensive effects.
    Knutsen LJ; Lau J; Petersen H; Thomsen C; Weis JU; Shalmi M; Judge ME; Hansen AJ; Sheardown MJ
    J Med Chem; 1999 Sep; 42(18):3463-77. PubMed ID: 10479279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of adenosine as a modulator of synaptic activity in the central nervous system.
    Brundege JM; Dunwiddie TV
    Adv Pharmacol; 1997; 39():353-91. PubMed ID: 9160120
    [No Abstract]   [Full Text] [Related]  

  • 34. Caffeine and Its Neuroprotective Role in Ischemic Events: A Mechanism Dependent on Adenosine Receptors.
    Pereira-Figueiredo D; Nascimento AA; Cunha-Rodrigues MC; Brito R; Calaza KC
    Cell Mol Neurobiol; 2022 Aug; 42(6):1693-1725. PubMed ID: 33730305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenosine receptors and brain diseases: neuroprotection and neurodegeneration.
    Gomes CV; Kaster MP; Tomé AR; Agostinho PM; Cunha RA
    Biochim Biophys Acta; 2011 May; 1808(5):1380-99. PubMed ID: 21145878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenosine and the nervous system: pharmacological data and therapeutic perspectives.
    Guieu R; Dussol B; Halimi G; Bechis G; Sampieri F; Berland Y; Sampol J; Couraud F; Rochat H
    Gen Pharmacol; 1998 Oct; 31(4):553-61. PubMed ID: 9792214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of endogenous adenosine levels in the CNS: potential for therapy in stroke, epilepsy and pain.
    Foster AC; Miller LP; Wiesner JB
    Adv Exp Med Biol; 1994; 370():427-30. PubMed ID: 7660943
    [No Abstract]   [Full Text] [Related]  

  • 38. The physiological role of adenosine in the central nervous system.
    Dunwiddie TV
    Int Rev Neurobiol; 1985; 27():63-139. PubMed ID: 2867982
    [No Abstract]   [Full Text] [Related]  

  • 39. Regulatory functions of adenosine.
    Ohisalo JJ
    Med Biol; 1987; 65(4):181-91. PubMed ID: 3325699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Adenosine - a mediator with multisystemic effects (or a hormone?)].
    Lazúrová Z; Mitro P
    Vnitr Lek; 2017; 63(9):617-623. PubMed ID: 29120660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.